Articles dans des revues avec comité de lecture (33)
1.
Fagnoul, S., Ghisdal, L., Marangoni, M., Detry, C., Dacremont-Rodrigues, P., Bisteau, X., Imbault, V., Catalano, C., Smits, G., Le Moine, A., & Migeotte, I. (2026). A Partial UMOD Deletion Results in Altered UMOD Synthesis and ADTKD. Kidney Medicine, 101265. doi:10.1016/j.xkme.2026.1012652.
Tangeten, C., Bourez, A., Rousseau, A., Imbault, V., Stahl-Zeng, J., Souard, F., Bisteau, X., Delporte, C., Zouaoui Boudjeltia, K., & Van Antwerpen, P. (2025). Untargeted metabolomics and proteomics reveal the versatile effects of myeloperoxidase-oxidized LDL on endothelial cells. Biochimica et biophysica acta (G). General subjects, 1869(12), 130865. doi:10.1016/j.bbagen.2025.1308653.
Grosbois, J., Bisteau, X., Imbault, V., Conrard, L., Condorelli, M., Findikli, N., Lybaert, P., & Demeestere, I. (2025). Proteomic profiling reveals the molecular signatures of chemotherapy-induced human ovarian damage. Human reproduction, 40(12), 2395-2408. doi:10.1093/humrep/deaf2034.
Ramos, A. R., Bregni, G., Gillet, N., Ando, K., Bodart, C., Vercauteren Drubbel, A., Descampe, L., Moresi, F., Bisteau, X., Verheye, Q., Pirard, S., Erneux, C., & Beck, B. (2025). SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma. Molecular cancer.5.
Kosa, A.-C., López Gutiérrez, L., Ando, K., Doeraene, E., Aydin, E., Lasri, H., Wathelet-Depauw, A., Pieters, K., Van Morckhoven, D., Imbault, V., Dubois, C., Bisteau, X., Stamatopoulos, B., Igoillo Esteve, M., Brion, J. P., & Leroy, K. (2025). Differential effects of age and sex on tau pathology propagation in the htau mouse model: a neuropathological and proteomic study. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(1), e70784. doi:doi.org/10.1002/alz.707846.
Moresi, F., Noto, F., Vasudevan, J., Bisteau, X., Adriani, G., & Pavesi, A. (2025). Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment-Integrated Organ-On-Chip Models. Advanced Therapeutics. doi:10.1002/adtp.2025000987.
Bande, M., Delporte, C., SAKIRA, A. K., Bourez, A., Imbault, V., Bisteau, X., Sombié, C., Some, T. I., & Van Antwerpen, P. (2025). Development of An Analytical Model for Assessing the Adsorptive Properties of Traditional Medicinal Formulations from Burkina Faso in Relation to Snake Venom Proteins. Toxicon, 108470. doi:10.1016/j.toxicon.2025.1084708.
Raspé, E., Coulonval, K., Pita, J. M., Spinette, A., Ruscas-Craciun, L. I., Sandras, F., Libert, F., Lefort, A., Demetter, P., Van Caloen, G., Zhang, L., Quian, W., Guo, S., Larsimont, D., Bisteau, X., Machiels, J. P., & Roger, P. P. (2025). Absence of phosphorylated CDK4, a biomarker of intrinsic resistance to CDK4/6 inhibitors in head and neck squamous cell carcinoma, can be predicted by their gene expression profile. medRxiv : the preprint server for health sciences, 2025.11.10.25339594. doi:10.1101/2025.11.10.253395949.
Kaafarani, A., Darche-Gabinaud, R., Bisteau, X., Imbault, V., Wittamer, V., Parmentier, M., & Pirson, I. (2023). Proximity Interactome Analysis of Super Conserved Receptors Expressed in the Brain Identifies EPB41L2, SLC3A2, and LRBA as Main Partners. Cells, 12(22), 2625. doi:10.3390/cells1222262510.
Paternot, S., Raspé, E., Meiller, C., Tarabichi, M., Assié, J.-B., Libert, F., Remmelink, M., Bisteau, X., Pauwels, P., Blum, Y., Le Stang, N., TABONE-EGLINGER, S., Galateau-Salle, F., Blanquart, C., van Meerbeeck, J. P., Berghmans, T., Jean, D., & Roger, P. P. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. Molecular Oncology. doi:https://doi.org/10.1002/1878-0261.1335111.
Rovira I Berger, M., Miserocchi, M., Montanari, A., Hammou, L., Chomette, L., Pozo Gomez, J., Imbault, V., Bisteau, X., & Wittamer, V. (2022). Zebrafish Galectin 3 binding protein is the target antigen of the microglial 4C4 monoclonal antibody. Developmental dynamics. doi:10.1002/dvdy.54912.
Redondo Marin, J. A., Bibes, R., Vercauteren Drubbel, A., Dassy, B., Bisteau, X., Maury, E., & Beck, B. (2021). PER2 Circadian Oscillation Sensitizes Esophageal Cancer Cells to Chemotherapy. Biology, 10(4), 266. doi:10.3390/biology10040266